Emancipation Management’s Bristol-Myers Squibb BMY Stock Holding History

Emancipation Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,196	Closed	-$204K	–	42
2017 Q3	$204K	Buy	+3,196	New	+$187K	0.29%	37
2016 Q3	–	Sell	-3,396	Closed	-$249K	–	42
2016 Q2	$249K	Hold	3,396	–	–	0.3%	41
2016 Q1	$216K	Sell	3,396 -30	-0.9%	-$1.89K	0.28%	43
2015 Q4	$229K	Hold	3,426	–	–	0.21%	43
2015 Q3	$202K	Hold	3,426	–	–	0.19%	41
2015 Q2	$228K	Buy	+3,426	New	+$226K	0.19%	52

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emancipation Management's BMY Position: Q4 2017 in Review

Emancipation Management sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,196 shares — an estimated $204K sold.

Emancipation Management first reported a position in BMY in Q2 2015 and held it in 6 quarters. The position peaked at $249K in Q2 2016. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Emancipation Management reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
Emancipation Management sold 3,196 Bristol-Myers Squibb shares in Q4 2017, an estimated $204K.
Emancipation Management first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 6 quarters.
Emancipation Management's Bristol-Myers Squibb position peaked at $249K in Q2 2016.
1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Emancipation Management's 13F filing for Q4 2017, filed 12 Feb 2018.